DNA methylation in cancer
We are actively investigating how abnormalities in the DNA methylation machinery contribute to transformation (see for instance Roussel-Gervais et al Cancer Res. 2017, Naciri et al NAR 2019). Projects that are currently ongoing use advanced genetics and genomics, such as degron alleles coupled with WGBS, and have the long-term goal of designing more efficient epigenetic therapies for cancer.
UHRF1 intensity at different timepoints before (left) and after (right) auxin addition in culture media.
In this cell line, the protein UHRF1 is fused to a green fluorescent protein (GFP) and can be degraded after auxin addition in culture media.
Read more
Postdoctoral position in epigenetics and cancer
Applications are invited for a 3-year postdoctoral position in the laboratory of Dr. Sophie Polo. The position is available from January 2025 (open until filled). The proposed postdoctoral work aims at targeting the DNA repair defect that we identified in histone H3...
EDC15: Fifteen Years of Epigenetics and Cell Fate
The Epigenetics and Cell Fate Center celebrates its fifteen years of existence on October 8, 2024. Come, and join us for this special day! This conference will look back on 15 years of scientific advances in the fields of epigenetics and cellular differentiation in...
2024 Young Scientists Day
It’s time to create our own network! The 27th of June young scientists from BFA (Biologie Fonctionelle Adaptative), IJM (Institut Jacques Monod) and us (EDC) will meet to share amazing science and create the foundations of future collaborations...
Call for new Research Group Leaders
The Epigenetics and Cell Fate Centre is seeking to recruit two talented junior and/or senior group leaders.Download the call (.pdf) Download the application form (.doc) The Epigenetics and Cell Fate Centre is a leading institute exploring cell identity and...